Invention Grant
US07935695B2 1,4-diaza-bicyclo[3.2.2]nonyl heteroaryl derivatives useful as nicotinic acetylcholine receptor ligands
失效
可用作烟碱乙酰胆碱受体配体的1,4-二氮杂双环[3.2.2]壬基杂芳基衍生物
- Patent Title: 1,4-diaza-bicyclo[3.2.2]nonyl heteroaryl derivatives useful as nicotinic acetylcholine receptor ligands
- Patent Title (中): 可用作烟碱乙酰胆碱受体配体的1,4-二氮杂双环[3.2.2]壬基杂芳基衍生物
-
Application No.: US12733168Application Date: 2008-08-14
-
Publication No.: US07935695B2Publication Date: 2011-05-03
- Inventor: Dan Peters , Daniel B. Timmermann , Elsebet Ostergaard Nielsen , Gunnar M. Olsen , Tino Dyhring , Jeppe Kejser Christensen
- Applicant: Dan Peters , Daniel B. Timmermann , Elsebet Ostergaard Nielsen , Gunnar M. Olsen , Tino Dyhring , Jeppe Kejser Christensen
- Applicant Address: DK Ballerup
- Assignee: Neurosearch A/S
- Current Assignee: Neurosearch A/S
- Current Assignee Address: DK Ballerup
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: DK200701178 20070817
- International Application: PCT/EP2008/060654 WO 20080814
- International Announcement: WO2009/024517 WO 20090226
- Main IPC: A61K31/55
- IPC: A61K31/55 ; C07D243/00 ; C07D487/22 ; C07D491/00 ; C07D498/00
![1,4-diaza-bicyclo[3.2.2]nonyl heteroaryl derivatives useful as nicotinic acetylcholine receptor ligands](/abs-image/US/2011/05/03/US07935695B2/abs.jpg.150x150.jpg)
Abstract:
This invention relates to novel 1,4-diaza-bicyclo[3.2.2]nonyl heteroaryl derivatives and their use in the manufacture of pharmaceutical compositions. The compounds of the invention are found to be cholinergic ligands at the nicotinic acetylcholine receptors.Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.
Public/Granted literature
Information query